Literature DB >> 17760644

Reversible optic neuropathy due to metronidazole.

Nicole M McGrath, Brian Kent-Smith, Dianne M Sharp.   

Abstract

Metronidazole is a little known cause of drug-induced optic neuropathy. We report a patient who developed progressive visual loss after an 8-month course of Metronidazole. Electrophysiology confirmed a bilateral optic neuropathy. Her vision improved dramatically with cessation of the drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17760644     DOI: 10.1111/j.1442-9071.2007.01537.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  14 in total

1.  Cases: Reversible cerebellar syndrome caused by metronidazole.

Authors:  Justyna R Sarna; A Keith W Brownell; Sarah Furtado
Journal:  CMAJ       Date:  2009-09-14       Impact factor: 8.262

2.  Metronidazole-induced central and peripheral nervous system toxicity.

Authors:  G Cação; S Fontes; M Salgado; T Rodrigues; Joana Damásio
Journal:  Neurol Sci       Date:  2015-05-20       Impact factor: 3.307

3.  Antibiotic-induced neurotoxicity.

Authors:  Shamik Bhattacharyya; Ryan Darby; Aaron L Berkowitz
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

4.  Neurological and Psychiatric Adverse Effects of Antimicrobials.

Authors:  Madison K Bangert; Rodrigo Hasbun
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

Review 5.  Neurotoxic effects associated with antibiotic use: management considerations.

Authors:  Marie F Grill; Rama K Maganti
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

6.  Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis.

Authors:  Matthew W Carroll; Doosoo Jeon; James M Mountz; Jong Doo Lee; Yeon Joo Jeong; Nadeem Zia; Myungsun Lee; Jongseok Lee; Laura E Via; Soyoung Lee; Seok-Yong Eum; Sung-Joong Lee; Lisa C Goldfeder; Ying Cai; Boyoung Jin; Youngran Kim; Taegwon Oh; Ray Y Chen; Lori E Dodd; Wenjuan Gu; Veronique Dartois; Seung-Kyu Park; Cheon Tae Kim; Clifton E Barry; Sang-Nae Cho
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

7.  Clinical efficacy of 12-h metronidazole dosing regimens in patients with anaerobic or mixed anaerobic infections.

Authors:  Ashley F Soule; Sarah B Green; Lisa M Blanchette
Journal:  Ther Adv Infect Dis       Date:  2018-04-03

8.  Metronidazole-Induced Irreversible Optic Neuropathy.

Authors:  Pai-Huei Peng; Tzu-En Wu; Ting-Yu Lin
Journal:  Case Rep Ophthalmol       Date:  2021-05-10

9.  Metronidazole induced cerebellar ataxia.

Authors:  Aditya Hari; B Akshaya Srikanth; G Sriranga Lakshmi
Journal:  Indian J Pharmacol       Date:  2013 May-Jun       Impact factor: 1.200

10.  Metronidazole-induced encephalopathy in a patient with infectious colitis: a case report.

Authors:  Hoon Kim; Young Woo Kim; Seoung Rim Kim; Ik Seong Park; Kwang Wook Jo
Journal:  J Med Case Rep       Date:  2011-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.